Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Viridian Therapeutics Inc (1S1)

Frankfurt
Currency in EUR
18.100
-0.600(-3.21%)
Closed
1S1 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
18.10018.100
52 wk Range
10.50023.400
Key Statistics
Edit
Bid/Ask
18.50 / 18.90
Prev. Close
18.7
Open
18.1
Day's Range
18.1-18.1
52 wk Range
10.5-23.4
Volume
1
Average Volume (3m)
20
1-Year Change
6.47%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1S1 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
40.620
Upside
+105.984%
Members' Sentiments
Bearish
Bullish
ProTips
6 analysts have revised their earnings downwards for the upcoming period
Show more

Viridian Therapeutics Inc Company Profile

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company’s product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.

Compare 1S1 to Peers and Sector

Metrics to compare
1S1
Peers
Sector
Relationship
P/E Ratio
−6.1x−3.9x−0.7x
PEG Ratio
−0.37−0.080.00
Price/Book
3.0x1.5x2.6x
Price / LTM Sales
5,172.4x4.7x3.2x
Upside (Analyst Target)
-183.6%46.6%
Fair Value Upside
Unlock19.0%7.4%Unlock

FAQ

What Is the Viridian Therapeutics (1S1) Stock Price Today?

The Viridian Therapeutics stock price today is 18.10

What Stock Exchange Does Viridian Therapeutics Trade On?

Viridian Therapeutics is listed and trades on the Frankfurt stock exchange.

What Is the Stock Symbol for Viridian Therapeutics?

The stock symbol for Viridian Therapeutics is "1S1."

What Is the Viridian Therapeutics Market Cap?

As of today, Viridian Therapeutics market cap is 1.48B.

What is Viridian Therapeutics Earnings Per Share?

The Viridian Therapeutics EPS is -4.26.

From a Technical Analysis Perspective, Is 1S1 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.